Evidence map›Paper›PMID 39227160›Full record

ArticleJournal of medical genetics2024

The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification.

Charlie F Rowlands, Alice Garrett, Sophie Allen, Miranda Durkie, George J Burghel, Rachel Robinson, Alison Callaway, Joanne Field, Bethan Frugtniet, Sheila Palmer-Smith and 9 more

Abstract read
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Charlie F Rowlands *Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0001-5333-4846
Alice Garrett *Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0001-8942-283X
Sophie AllenDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0003-4928-2240
Miranda DurkieSheffield Diagnostic Genetics Service, NEY Genomic Laboratory Hub, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
George J BurghelManchester Centre for Genomic Medicine and NW Laboratory Genetics Hub, Manchester University NHS Foundation Trust, Manchester, UK.ORCID 0000-0001-9360-8194
Rachel RobinsonThe Leeds Genetics Laboratory, NEY Genomic Laboratory Hub, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Alison CallawayWessex Genetics Laboratory Service, University Hospital Southampton NHS Foundation Trust, Salisbury, UK.
Joanne FieldGenomics and Molecular Medicine Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Bethan FrugtnietSt George's University Hospitals NHS Foundation Trust, London, UK.
Sheila Palmer-SmithInstitute of Medical Genetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK.
Jonathan GrantWest of Scotland Centre for Genomic Medicine, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, G51 4TF, UK.
Judith PaganSouth East Scotland Clinical Genetics, Western General Hospital, Edinburgh, UK.
Trudi McDevittCHI Crumlin Department of Clinical Genetics, Dublin, Ireland.
Terri P McVeighThe Royal Marsden NHS Foundation Trust, London, UK.
Helen HansonPeninsula Regional Genetics Service, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.ORCID 0000-0002-3303-8713
Nicola WhiffinBig Data Institute, University of Oxford, Oxford, UK.
Michael JonesDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Clare TurnbullDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK turnbull.lab@icr.ac.uk.ORCID 0000-0002-3797-7398
CanVIG-UK

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe 2015 American College of Medical Genetics/Association of Molecular Pathology (ACMG/AMP) variant classification framework specifies that case-control observations can be scored as 'strong' evidence (PS4) towards pathogenicity.

methodsWe developed the PS4-likelihood ratio calculator (PS4-LRCalc) for quantitative evidence assignment based on the observed variant frequencies in cases and controls. Binomial likelihoods are computed for two models, each defined by prespecified OR thresholds. Model 1 represents the hypothesis of association between variant and phenotype (eg, OR≥5) and model 2 represents the hypothesis of non-association (eg, OR≤1).

resultsPS4-LRCalc enables continuous quantitation of evidence for variant classification expressed as a likelihood ratio (LR), which can be log-converted into log LR (evidence points). Using PS4-LRCalc, observed data can be used to quantify evidence towards either pathogenicity or benignity. Variants can also be evaluated against models of different penetrance. The approach is applicable to balanced data sets generated for more common phenotypes and smaller data sets more typical in very rare disease variant evaluation.

conclusionPS4-LRCalc enables flexible evidence quantitation on a continuous scale for observed case-control data. The converted LR is amenable to incorporation into the now widely used 2018 updated Bayesian ACMG/AMP framework.

Indexed as

Genetic VariationCase-Control StudiesGenetic Predisposition to DiseaseHumansLikelihood FunctionsPenetrancePhenotypeGeneticsGenetics, PopulationGenetic TestingGenetic Variation

Identifiers

PMID39227160
PMCPMC11503184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.